{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:55:05Z","timestamp":1791114905120,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Lithium salt is a widely used glycogen synthase kinase-3\u03b2 inhibitor and effective drug for the treatment of psychiatric diseases. However, the effects of lithium in innate immune responses, especially in cellular antiviral responses, are unknown. In this study, we show that lithium chloride attenuates LPS-, polyinosinic-polycytidylic acid\u2013, and Sendai virus\u2013induced IFN-\u03b2 production and IFN regulatory factor 3 activation in macrophages in a glycogen synthase kinase-3\u03b2\u2013independent manner. The ability of the lithium to inhibit IFN-\u03b2 production was confirmed in vivo, as mice treated with lithium chloride exhibited decreased levels of IFN-\u03b2 upon Sendai virus infection. In vitro kinase assay demonstrates that lithium suppresses TANK-binding kinase 1 kinase activity. Consistently, lithium significantly enhanced the replication of vesicular stomatitis virus in vitro and in vivo. Severe infiltration of monocytes and tissue damage were observed in the lungs of control mice, compared with lithium-treated mice after virus infection. Our findings suggest lithium as an inhibitor of TANK-binding kinase 1 and potential target for the intervention of diseases with uncontrolled IFN-\u03b2 production. Furthermore, lithium attenuates host defense to virus infection and may cause severely adverse effects in clinical applications.<\/jats:p>","DOI":"10.4049\/jimmunol.1203142","type":"journal-article","created":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T04:14:53Z","timestamp":1379391293000},"page":"4392-4398","source":"Crossref","is-referenced-by-count":24,"title":["Lithium Attenuates IFN-\u03b2 Production and Antiviral Response via Inhibition of TANK-Binding Kinase 1 Kinase Activity"],"prefix":"10.1093","volume":"191","author":[{"given":"Lijuan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Immunology, Shandong University School of Medicine , Jinan, Shandong 250012,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Immunology, Shandong University School of Medicine , Jinan, Shandong 250012,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Immunology, Shandong University School of Medicine , Jinan, Shandong 250012,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Immunology, Shandong University School of Medicine , Jinan, Shandong 250012,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Immunology, Shandong University School of Medicine , Jinan, Shandong 250012,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjiang","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Immunology, Shandong University School of Medicine , Jinan, Shandong 250012,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,10,15]]},"reference":[{"key":"2025032405451605000_r1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"2025032405451605000_r2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-065X.2008.00701.x","article-title":"The interleukin-1 receptor\/Toll-like receptor superfamily: 10 years of progress","volume":"226","author":"O\u2019Neill","year":"2008","journal-title":"Immunol. Rev."},{"key":"2025032405451605000_r3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"2025032405451605000_r4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.immuni.2011.05.003","article-title":"Immune signaling by RIG-I-like receptors","volume":"34","author":"Loo","year":"2011","journal-title":"Immunity"},{"key":"2025032405451605000_r5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.mp.4000494","article-title":"Anti-bipolar therapy: mechanism of action of lithium","volume":"4","author":"Jope","year":"1999","journal-title":"Mol. Psychiatry"},{"key":"2025032405451605000_r6","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A molecular mechanism for the effect of lithium on development","volume":"93","author":"Klein","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032405451605000_r7","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00018-007-7045-7","article-title":"Glycogen synthase kinase 3: a key regulator of cellular fate","volume":"64","author":"Forde","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"2025032405451605000_r8","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1476-5381.2008.00085.x","article-title":"Glycogen synthase kinase 3: more than a namesake","volume":"156","author":"Rayasam","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"2025032405451605000_r9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2009.09.007","article-title":"Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)","volume":"31","author":"Beurel","year":"2010","journal-title":"Trends Immunol."},{"key":"2025032405451605000_r10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni1221","article-title":"Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3","volume":"6","author":"Martin","year":"2005","journal-title":"Nat. Immunol."},{"key":"2025032405451605000_r11","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.4049\/jimmunol.181.10.6797","article-title":"IFN-\u03b2 production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-\u03b2","volume":"181","author":"Wang","year":"2008","journal-title":"J. Immunol."},{"key":"2025032405451605000_r12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.immuni.2010.11.021","article-title":"Glycogen synthase kinase 3\u03b2 regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1","volume":"33","author":"Lei","year":"2010","journal-title":"Immunity"},{"key":"2025032405451605000_r13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.neuropharm.2007.08.018","article-title":"Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells","volume":"53","author":"Yanagita","year":"2007","journal-title":"Neuropharmacology"},{"key":"2025032405451605000_r14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bone.2010.09.033","article-title":"Lithium chloride attenuates BMP-2 signaling and inhibits osteogenic differentiation through a novel WNT\/GSK3-independent mechanism","volume":"48","author":"Li","year":"2011","journal-title":"Bone"},{"key":"2025032405451605000_r15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0162-0134(00)80191-9","article-title":"Rat-brain pyruvate kinase: purification and effects of lithium","volume":"11","author":"Kajda","year":"1979","journal-title":"J. Inorg. Biochem."},{"key":"2025032405451605000_r16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1146\/annurev.pharmtox.41.1.789","article-title":"Molecular targets of lithium action","volume":"41","author":"Phiel","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2025032405451605000_r17","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1083\/jcb.200504035","article-title":"Lithium induces autophagy by inhibiting inositol monophosphatase","volume":"170","author":"Sarkar","year":"2005","journal-title":"J. Cell Biol."},{"key":"2025032405451605000_r18","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.4049\/jimmunol.1103506","article-title":"Tripartite motif-containing protein 38 negatively regulates TLR3\/4- and RIG-I-mediated IFN-\u03b2 production and antiviral response by targeting NAP1","volume":"188","author":"Zhao","year":"2012","journal-title":"J. Immunol."},{"key":"2025032405451605000_r19","doi-asserted-by":"crossref","first-page":"20452","DOI":"10.1074\/jbc.M110.110312","article-title":"Differential expression of intracellular and secreted osteopontin isoforms by murine macrophages in response to Toll-like receptor agonists","volume":"285","author":"Zhao","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2025032405451605000_r20","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1084\/jem.20120024","article-title":"TRAF-interacting protein (TRIP) negatively regulates IFN-\u03b2 production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1","volume":"209","author":"Zhang","year":"2012","journal-title":"J. Exp. Med."},{"key":"2025032405451605000_r21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.cell.2011.09.022","article-title":"Activation of STAT6 by STING is critical for antiviral innate immunity","volume":"147","author":"Chen","year":"2011","journal-title":"Cell"},{"key":"2025032405451605000_r22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1074-7613(02)00390-4","article-title":"IRF3 mediates a TLR3\/TLR4-specific antiviral gene program","volume":"17","author":"Doyle","year":"2002","journal-title":"Immunity"},{"key":"2025032405451605000_r23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"2025032405451605000_r24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ni921","article-title":"IKK\u03b5 and TBK1 are essential components of the IRF3 signaling pathway","volume":"4","author":"Fitzgerald","year":"2003","journal-title":"Nat. Immunol."},{"key":"2025032405451605000_r25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","article-title":"Type I interferons in host defense","volume":"25","author":"Stetson","year":"2006","journal-title":"Immunity"},{"key":"2025032405451605000_r26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.febslet.2013.01.052","article-title":"Negative regulation of TBK1-mediated antiviral immunity","volume":"587","author":"Zhao","year":"2013","journal-title":"FEBS Lett."},{"key":"2025032405451605000_r27","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.4049\/jimmunol.0902589","article-title":"Absence of SHIP-1 results in constitutive phosphorylation of tank-binding kinase 1 and enhanced TLR3-dependent IFN-\u03b2 production","volume":"184","author":"Gabhann","year":"2010","journal-title":"J. Immunol."},{"key":"2025032405451605000_r28","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.cellsig.2012.06.017","article-title":"PPM1B negatively regulates antiviral response via dephosphorylating TBK1","volume":"24","author":"Zhao","year":"2012","journal-title":"Cell. Signal."},{"key":"2025032405451605000_r29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.immuni.2011.06.014","article-title":"Mapping a dynamic innate immunity protein interaction network regulating type I interferon production","volume":"35","author":"Li","year":"2011","journal-title":"Immunity"},{"key":"2025032405451605000_r30","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/ni.1742","article-title":"The E3 ubiquitin ligase Nrdp1 \u201cpreferentially\u201d promotes TLR-mediated production of type I interferon","volume":"10","author":"Wang","year":"2009","journal-title":"Nat. Immunol."},{"key":"2025032405451605000_r31","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4049\/jimmunol.174.3.1507","article-title":"A20 is a negative regulator of IFN regulatory factor 3 signaling","volume":"174","author":"Saitoh","year":"2005","journal-title":"J. Immunol."},{"key":"2025032405451605000_r32","doi-asserted-by":"crossref","first-page":"14999","DOI":"10.1074\/jbc.M110.109819","article-title":"TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases","volume":"285","author":"Parvatiyar","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2025032405451605000_r33","doi-asserted-by":"crossref","first-page":"36592","DOI":"10.1074\/jbc.M111.283762","article-title":"ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling","volume":"286","author":"Gao","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2025032405451605000_r34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ni.2239","article-title":"NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4","volume":"13","author":"Cui","year":"2012","journal-title":"Nat. Immunol."},{"key":"2025032405451605000_r35","doi-asserted-by":"crossref","first-page":"14277","DOI":"10.1074\/jbc.M709731200","article-title":"Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation","volume":"283","author":"McCoy","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2025032405451605000_r36","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.175.5.3339","article-title":"Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex","volume":"175","author":"Youn","year":"2005","journal-title":"J. Immunol."},{"key":"2025032405451605000_r37","doi-asserted-by":"crossref","first-page":"21170","DOI":"10.1073\/pnas.1119137109","article-title":"I\u03baB kinase \u03b5 (IKK\u03b5) regulates the balance between type I and type II interferon responses","volume":"108","author":"Ng","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032405451605000_r38","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.1136567","article-title":"Multiple functions of the IKK-related kinase IKK\u03b5 in interferon-mediated antiviral immunity","volume":"315","author":"Tenoever","year":"2007","journal-title":"Science"},{"key":"2025032405451605000_r39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.celrep.2013.01.034","article-title":"Crystal structure and mechanism of activation of TANK-binding kinase 1","volume":"3","author":"Larabi","year":"2013","journal-title":"Cell Rep"},{"key":"2025032405451605000_r40","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1006\/bbrc.2000.4169","article-title":"Lithium inhibits glycogen synthase kinase-3 by competition for magnesium","volume":"280","author":"Ryves","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2025032405451605000_r41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10534-012-9607-x","article-title":"Lithium enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells","volume":"26","author":"Lan","year":"2013","journal-title":"Biometals"},{"key":"2025032405451605000_r42","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1021\/ja201985s","article-title":"Competition between Li+ and Mg2+ in metalloproteins. Implications for lithium therapy","volume":"133","author":"Dudev","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"2025032405451605000_r43","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1378-1","article-title":"Wnt and lithium: a common destiny in the therapy of nervous system pathologies?","volume-title":"Cell. Mol. Life Sci.","author":"Meffre","year":"2013"},{"key":"2025032405451605000_r44","doi-asserted-by":"crossref","first-page":"17406","DOI":"10.1073\/pnas.0505259102","article-title":"Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice","volume":"102","author":"Cl\u00e9ment-Lacroix","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032405451605000_r45","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1182\/blood-2007-03-077685","article-title":"Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo","volume":"111","author":"Edwards","year":"2008","journal-title":"Blood"},{"key":"2025032405451605000_r46","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3\u03b2 phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"key":"2025032405451605000_r47","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4049\/jimmunol.181.1.338","article-title":"Lithium prevents and ameliorates experimental autoimmune encephalomyelitis","volume":"181","author":"De Sarno","year":"2008","journal-title":"J. Immunol."},{"key":"2025032405451605000_r48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type I interferons","volume":"12","author":"Gonz\u00e1lez-Navajas","year":"2012","journal-title":"Nat. Rev. Immunol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/191\/8\/4392\/62508242\/1203142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/191\/8\/4392\/62508242\/1203142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T06:09:36Z","timestamp":1742882976000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/191\/8\/4392\/7966387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,10,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1203142","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,10]]},"published":{"date-parts":[[2013,10]]}}}